Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Madrigal Pharmaceuticals Inc (NQ: MDGL ) 275.66 +0.97 (+0.35%) Streaming Delayed Price Updated: 1:43 PM EDT, Jul 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 97,022 Open 275.25 Bid (Size) 274.83 (4) Ask (Size) 277.60 (4) Prev. Close 274.69 Today's Range 270.77 - 278.94 52wk Range 119.76 - 299.98 Shares Outstanding 17,103,395 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 7 Biotech Stocks to Keep on Your Clinical Radar July 23, 2024 Biotech stocks have always been relevant. However, with the latest shift in the political race, this sector is bound to grab more eyeballs. Via InvestorPlace Is Madrigal Pharmaceuticals a Millionaire Maker? June 30, 2024 Its revenue ramp-up is just starting, and its market looks lucrative. Via The Motley Fool Performance YTD +21.51% +21.51% 1 Month -1.31% -1.31% 3 Month +37.10% +37.10% 6 Month +21.44% +21.44% 1 Year +34.27% +34.27% More News Read More Is Madrigal Pharmaceuticals Stock a Buy? June 28, 2024 Via The Motley Fool The Best Biotech Stock to Invest $1,000 in Right Now June 18, 2024 Via The Motley Fool Gilead Has A Narrative-Changing Revelation For Its Weight-Loss Contender June 17, 2024 Via Investor's Business Daily Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word. June 16, 2024 Via The Motley Fool Is Madrigal Pharmaceuticals Stock a Buy? May 21, 2024 Via The Motley Fool 2 Under-the-Radar Growth Stocks to Consider April 10, 2024 Via The Motley Fool 1 No-Brainer Growth Stock to Buy Now April 03, 2024 Via The Motley Fool Where Will Madrigal Pharmaceuticals Be in 3 Years? June 15, 2024 Via The Motley Fool Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade June 12, 2024 Via Investor's Business Daily 10 Health Care Stocks With Whale Alerts In Today's Session June 11, 2024 Via Benzinga Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals June 10, 2024 Via The Motley Fool What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday? June 05, 2024 Via Benzinga Madrigal, Akero, 89bio Tumble After Lilly's Weight-Loss Drug Tackles MASH June 05, 2024 Via Investor's Business Daily DouYu International Posts Q1 Results, Joins Annexon, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session June 05, 2024 Via Benzinga Viking Therapeutics Stock Crumbles Despite Potential 'Best-In-Class' Liver Disease Drug June 04, 2024 Via Investor's Business Daily The Week Ahead: What's Next June 02, 2024 Via Talk Markets MDGL Stock Earnings: Madrigal Pharmaceuticals Misses EPS for Q1 2024 May 07, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 07, 2024 Via Benzinga 10 Health Care Stocks Whale Activity In Today's Session May 03, 2024 Via Benzinga 6 Stocks Positioned to Soar as Investors Focus on MASH April 22, 2024 Via TheNewswire.com 7 Stocks Analysts Are Loving Right Now (And You Should Too): April 2024 April 15, 2024 Via InvestorPlace Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics April 05, 2024 Via The Motley Fool The 3 Best Biotech Stocks to Buy in April 2024 April 01, 2024 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
